drugset / Trial / NCT00083824

Estrogen, HDL, and Coronary Heart Disease in Women

NCT00083824

RandomizedParallel-groupQuadruple-blindHealth-services research

Summary

To clarify the effects of estrogen, with or without progestin, on high density lipoprotein (HDL) in postmenopausal women.

Timeline

Start
2004-03
Primary completion
2007-02
Completion
2007-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject conjugated estrogens Other / unclassified 0.625 mg
Subject medroxyprogesterone acetate Other / unclassified 2.5 mg